Increased leukocyte-endothelial cell adhesion is a key early event in the development of retinopathy and atherogenesis in diabetic patients. We recently reported that raised activity of glycosylating enzyme []1,6 acetylglucosaminyltransferase (core 2 GlcNAc-T) is responsible for increased leukocyte-endothelial cell adhesion and capillary occlusion in retinopathy. Here, we demonstrate that elevated glucose increases the activity of core 2 GlcNAc-T and adhesion of human leukocytes to retinal capillary endothelial cells, in a dose-dependent manner, through diabetes-activated serine/threonine protein kinase C 2 (PKC2)-dependent phosphorylation. This regulatory mechanism, involving phosphorylation of core 2 GlcNAc-T, is also present in polymorphonuclear leukocytes isolated from type 1 and type 2 diabetic patients. Inhibition of PKC2 activation with the specific inhibitor, LY379196, attenuated serine phosphorylation of core 2 GlcNAc-T and prevented increased leukocyte-endothelial cell adhesion. Raised activity of core 2 GlcNAc-T was associated with a threefold increase in O-linked glycosylation of P-selectin glycoprotein ligand-1 on the surface of leukocytes of diabetic patients compared with age-matched control subjects. PKC2-dependent phosphorylation of core 2 GlcNAc-T may thus represent a novel regulatory mechanism for activation of this key enzyme in mediating increased leukocyte-endothelial cell adhesion and capillary occlusion in diabetic retinopathy. Diabetes 52: 1519 -1527, 2003 D iabetic retinopathy, a leading cause of severe visual loss in type 1 and type 2 diabetic patients (1) is characterized in its early stage by areas of capillary nonperfusion and microvascular damage (2,3). As in atherogenesis (4), increased leukocyteendothelial cell adhesion is a key early event in the development of capillary occlusion in retinopathy (5-10). Leukocytes from diabetic patients are more adhesive to endothelial cells (11), and in experimental diabetes, their increased entrapment in retinal capillaries leads to areas of capillary nonperfusion and endothelial cell damage (12). Increased adhesion of leukocytes in diabetic patients may result from an increased expression of intracellular adhesion molecule (ICAM)-1 on endothelial cells and/or expression of integrins (CD11a, CD11b, and CD18b) on leukocytes (13-16).We recently reported that raised activity of the glycosylating enzyme []1,6-acetylglucosaminyltransferase (core 2 GlcNAc-T) is responsible for increased leukocyte-endothelial cell adhesion and capillary occlusion in retinopathy (17). This Golgi enzyme plays a crucial role in the biosynthesis of O-linked glycans by converting core 1 (i.e., Gal (21), T-cell activation (22), inflammation (23), myocardial dysfunction (24,25), capillary morphogenesis (26), and myeloblastic leukemia (27). On the basis that O-linked sugars are also involved in cell-cell interactions (28), we proposed that their modification by raised activity of core 2 GlcNAc-T, together with glucose-induced expression of adhesion molecules on endoth...